Indegene Ltd
Thu 13/03/2025,15:53:33 | NSE : INDGN
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 526.80
Previous Close
₹ 522.55
Volume
819134
Mkt Cap ( Rs. Cr)
₹12281.67
High
₹ 538.00
Low
₹ 507.95
52 Week High
₹ 736.30
52 Week Low
₹ 470.10
Book Value Per Share
₹ 98.64
Dividend Yield
0.00
Face Value
₹ 2.00
What’s Your Call?
Collective community sentiment on Indegene Ltd
Your Vote -
Buy
75.00%
Hold
0.00%
Sell
25.00%
75.00%
4 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
513.30
61
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
61
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Indegene Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Indegene - Alteration Of Capital and Fund Raising-XBRL
-
Indegene - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Indegene - General Updates
-
Indegene - Intimation Of Outcome Of Resolution Passed By Circulation
-
Indegene - Analysts/Institutional Investor Meet/Con. Call Updates
-
Indegene - Press Release
-
Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Deloitte names Indegene a Winner of Enterprise Growth Awards 2025
-
Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Indegene - Updates
-
Indegene - Analysts/Institutional Investor Meet/Con. Call Updates
-
Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Indegene - Alteration Of Capital and Fund Raising-XBRL
-
Indegene - Updates
-
Indegene - Press Release
-
Indegene - Intimation Of Outcome Of Resolution Passed By Circulation Under Regulation 30 Of The SEBI (Listing Obligations And
-
Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Indegene - Analysts/Institutional Investor Meet/Con. Call Updates
-
Indegene - Analysts/Institutional Investor Meet/Con. Call Updates
-
Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Indegene - General Updates
-
Indegene - Intimation Of Resolution Proposed To Be Passed By Circulation.
-
Indegene - Intimation Regarding The Change Of Name Of Registrar And Transfer Agent ('RTA') From 'Link Intime India Private Li
-
Indegene - Updates
-
Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Indegene - Analysts/Institutional Investor Meet/Con. Call Updates
-
Indegene - Analysts/Institutional Investor Meet/Con. Call Updates
-
Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Indegene - Analysts/Institutional Investor Meet/Con. Call Updates
-
Indegene - Analysts/Institutional Investor Meet/Con. Call Updates
-
Indegene - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
-
Indegene - Monitoring Agency Report
-
Indegene - Integrated Filing (Financial)
-
Indegene - Integrated Filing- Financial
-
Indegene - Statement of deviation(s) or variation(s) under Reg. 32
-
Indegene - Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds For The Quarter Ended December 31, 2024
-
Indegene - Press Release
-
Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Indegene - Integrated Filing- Financial
-
Indegene - Integrated Filing (Financial)
-
Indegene - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
Indegene - Analysts/Institutional Investor Meet/Con. Call Updates
-
Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Indegene - Press Release
-
Indegene - Alteration Of Capital and Fund Raising-XBRL
-
Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Indegene - Analysts/Institutional Investor Meet/Con. Call Updates
-
Indegene - Trading Window
-
Indegene - Copy of Newspaper Publication
-
Indegene - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Indegene - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
-
Indegene - Alteration Of Capital and Fund Raising-XBRL
-
Indegene - Change in Auditors
-
Indegene - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Indegene Q3 net profit jumps 65.78% at Rs 49.90 cr
-
Indegene - Investor Presentation
-
Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Indegene - Press Release
-
Indegene - Financial Result Updates
-
Indegene - Outcome of Board Meeting
-
Indegene - Board Meeting Outcome for Intimation Of Outcome Of Board Meeting
-
Indegene - Results, Financial Results- Dec 2024
-
Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Indegene - Analysts/Institutional Investor Meet/Con. Call Updates
-
Indegene - Board Meeting Intimation
-
Indegene - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And
-
Indegene - Options to purchase securities
-
Indegene - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
-
Indegene has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024
-
Indegene - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Indegene - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Indegene - Press Release
-
Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Indegene - Press Release
-
Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Indegene - Trading Window-XBRL
-
Indegene - Trading Window
-
Indegene - General Updates
-
Indegene - Updates
-
Indegene - Updates
-
Indegene - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Indegene - Analysts/Institutional Investor Meet/Con. Call Updates
-
Indegene - Intimation Of Resolution Proposed To Be Passed By Circulation
-
Indegene - General Updates
-
Indegene - Updates
-
Indegene - Disclosure As Per Regulation 7(2) Of SEBI (PIT) Regulation, 2015
-
Indegene - Press Release
-
Indegene - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Indegene
-
Indegene announces strategic collaboration with Microsoft
Key fundamentals
Evaluate the intrinsic value of Indegene Ltd stock
Name | March-24 | March-23 | March-22 | March-21 | March-20 |
---|---|---|---|---|---|
Assets | 953.8 | 795.3 | 650 | 442.2 | 333.6 |
Liabilities | 953.8 | 795.3 | 650 | 442.2 | 333.6 |
Equity | 44.4 | 44.3 | 0.4 | 0.3 | 0.3 |
Gross Profit | 168 | 177.9 | 168.7 | 150.4 | 85.9 |
Net Profit | 137.9 | 130.2 | 132.7 | 133.4 | 31.7 |
Cash From Operating Activities | 176.2 | 81.9 | 38.2 | 54.6 | 89.6 |
NPM(%) | 13.18 | 12.94 | 15.85 | 26.1 | 9.47 |
Revenue | 1045.6 | 1005.7 | 836.7 | 511 | 334.5 |
Expenses | 877.6 | 827.8 | 668 | 360.6 | 248.6 |
ROE(%) | 5.84 | 5.51 | 5.62 | 5.65 | 1.34 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|
Peers
Other companies within the same industry or sector that are comparable to Indegene Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
Visagar Polytex Ltd | 0.82 | -3.53 | 0.00 | 15050.69 | -53.07 | 0.00 |
India Motor Parts and Accessories Ltd | 915.95 | -0.82 | 14.57 | 641.72 | 592.31 | 2.95 |
Madhya Pradesh Today Media Ltd | 29.10 | 0.00 | 4.99 | 234.89 | 55.30 | 0.00 |
Hathway Cable and Datacom Ltd | 13.20 | -1.35 | 25.38 | 91018.54 | 28.05 | 0.00 |
Company Info
Our Company was incorporated as `Indegene Lifesystems Private Limited' at Ahmedabad, Gujarat, as a private limited company, under the Companies Act, 1956, pursuant to a certificate of incorporation dated October 16, 1998, issued by the Registrar of Companies, Gujarat, Dadra & Nagar Haveli at Ahmedabad. Thereafter, the registered office of our Company was shifted from Gujarat to Karnataka in June 2003, and then, from Karnataka to Maharashtra in May 2014. Further, pursuant to a resolution passed by our Shareholders at the EGM held on February 29, 2016, the name of our Company was changed to `Indegene Private Limited' and a fresh certificate of incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016. The name of our Company was changed to better reflect the nature of business undertaken by our Company. Thereafter, the registered office of our Company was shifted from Maharashtra to Karnataka in February 2017. Subsequently, our Company was converted from a private limited company to a public limited company, pursuant to a special resolution passed by our Shareholders at the EGM held on November 7, 2022 and the name of our Company was changed to `Indegene Limited' and a fresh certificate of incorporation was issued to our Company by the RoC, on November 17, 2022.Major events and milestones:2005-Raised funding from Nadathur Holdings & Investments Private Limited-Expanded operations to the USA by incorporating a subsidiary named Indegene, Inc.-Expanded operations to Southeast Asia by incorporating a subsidiary named Indegene Fareast Pte. Ltd. in Singapore2006-Acquisition of Medsn, Inc.1 a company in the USA which is engaged in medical education and marketing business, by one of our Material Subsidiaries, Indegene, Inc.2 through the merger of Medsn Merger Sub, Inc., an erstwhile wholly owned subsidiary of Indegene, Inc. with Medsn, Inc.2007-Expanded our services to include European territory2008-Received BS ISO/IEC 27001:2005 certification for information security management system32009-Received ISO 9001:2000 certification for quality management system42012-Expanded operations to China by incorporating a subsidiary named Indegene Lifesystems Consulting (Shanghai) Co., Ltd.2017-Acquisition of the Encima Group, Inc., a corporation which operates a digital service, marketing automation and analytics services business supporting clients in healthcare, life sciences and other industries by one of our Material Subsidiaries, ILSL Holdings, Inc.2020-Acquisition of DT Associates Research and Consulting Services Limited, a consulting services company in UK supporting clients in healthcare, life sciences and other industries by one of our Material Subsidiaries, ILSL Holdings, Inc.-Launched Indegene Digital Summit, a symposium on digital transformation and customer experience in life sciences2021-Expanded operations to Japan by incorporating a subsidiary named Indegene Japan, LLC-Raised equity funding from CA Dawn Investments and Brighton Park Capital-Received BS ISO/IEC 27701:2019 certification for privacy information management system52022-Acquisition of Medical Marketing Economics, LLC by one of our Material Subsidiaries, ILSL Holdings, Inc. and subsequent merger of Medical Marketing Economics, LLC with Indegene, Inc.-Expanded global operations with new offices in Mexico2023-Acquisition of Cult Health, a company engaged in the business of providing advertising services to parties in the healthcare sector, by one of our Material Subsidiaries, ILSL Holdings, Inc.-Expanded our presence in Europe with the acquisition of Indegene Healthcare Germany GmbH (formerly Sotus 852 GmbH) by our subsidiary, Indegene Ireland Limited-Launched Invisage, an AI-enabled hybrid omnichannel sales and marketing platform2024-Acquisition of Trilogy Writing & Consulting GmbH, a company engaged in providing high-end medical writing to customers that include market-leading pharmaceutical companies, along with three of its wholly owned subsidiaries, by one of our Subsidiaries, Indegene Ireland Limited.-Ranked 167 in The Next 500 India's Largest Emerging Companies by Fortune India
Our Company was incorporated as `Indegene Lifesystems Private Limited' at Ahmedabad, Gujarat, as a private limited company, under the Companies Act, 1956, pursuant to a certificate of incorporation dated October 16, 1998, issued by the Registrar of Companies, Gujarat, Dadra & Nagar Haveli at Ahmedabad. Thereafter, the registered office of our Company was shifted from Gujarat to Karnataka in June 2003, and then, from Karnataka to Maharashtra in May 2014. Further, pursuant to a resolution passed by our Shareholders at the EGM held on February 29, 2016, the name of our Company was changed to `Indegene Private Limited' and a fresh certificate of incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016. The name of our Company was changed to better reflect the nature of business undertaken by our Company. Thereafter, the registered office of our Company was shifted from Maharashtra to Karnataka in February 2017. Subsequently, our Company was converted from a private limited company to a public limited company, pursuant to a special resolution passed by our Shareholders at the EGM held on November 7, 2022 and the name of our Company was changed to `Indegene Limited' and a fresh certificate of incorporation was issued to our Company by the RoC, on November 17, 2022.Major events and milestones:2005-Raised funding from Nadathur Holdings & Investments Private Limited-Expanded operations to the USA by incorporating a subsidiary named Indegene, Inc.-Expanded operations to Southeast Asia by incorporating a subsidiary named Indegene Fareast Pte. Ltd. in Singapore2006-Acquisition of Medsn, Inc.1 a company in the USA which is engaged in medical education and marketing business, by one of our Material Subsidiaries, Indegene, Inc.2 through the merger of Medsn Merger Sub, Inc., an erstwhile wholly owned subsidiary of Indegene, Inc. with Medsn, Inc.2007-Expanded our services to include European territory2008-Received BS ISO/IEC 27001:2005 certification for information security management system32009-Received ISO 9001:2000 certification for quality management system42012-Expanded operations to China by incorporating a subsidiary named Indegene Lifesystems Consulting (Shanghai) Co., Ltd.2017-Acquisition of the Encima Group, Inc., a corporation which operates a digital service, marketing automation and analytics services business supporting clients in healthcare, life sciences and other industries by one of our Material Subsidiaries, ILSL Holdings, Inc.2020-Acquisition of DT Associates Research and Consulting Services Limited, a consulting services company in UK supporting clients in healthcare, life sciences and other industries by one of our Material Subsidiaries, ILSL Holdings, Inc.-Launched Indegene Digital Summit, a symposium on digital transformation and customer experience in life sciences2021-Expanded operations to Japan by incorporating a subsidiary named Indegene Japan, LLC-Raised equity funding from CA Dawn Investments and Brighton Park Capital-Received BS ISO/IEC 27701:2019 certification for privacy information management system52022-Acquisition of Medical Marketing Economics, LLC by one of our Material Subsidiaries, ILSL Holdings, Inc. and subsequent merger of Medical Marketing Economics, LLC with Indegene, Inc.-Expanded global operations with new offices in Mexico2023-Acquisition of Cult Health, a company engaged in the business of providing advertising services to parties in the healthcare sector, by one of our Material Subsidiaries, ILSL Holdings, Inc.-Expanded our presence in Europe with the acquisition of Indegene Healthcare Germany GmbH (formerly Sotus 852 GmbH) by our subsidiary, Indegene Ireland Limited-Launched Invisage, an AI-enabled hybrid omnichannel sales and marketing platform2024-Acquisition of Trilogy Writing & Consulting GmbH, a company engaged in providing high-end medical writing to customers that include market-leading pharmaceutical companies, along with three of its wholly owned subsidiaries, by one of our Subsidiaries, Indegene Ireland Limited.-Ranked 167 in The Next 500 India's Largest Emerging Companies by Fortune India
Read More
Parent Organisation
Indegene Ltd.
Founded
16/10/1998
Managing Director
Mr.Manish Gupta
NSE Symbol
INDGNEQ
FAQ
The current price of Indegene Ltd is ₹ 513.30.
The 52-week high for Indegene Ltd is ₹ 538.00 and the 52-week low is ₹ 507.95.
The market capitalization of Indegene Ltd is currently ₹ 12281.67. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Indegene Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Indegene Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Indegene Ltd shares.
The CEO of Indegene Ltd is Mr.Manish Gupta, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.